Viracta Therapeutics, Inc.
Edit

Viracta Therapeutics, Inc.

http://www.viracta.com/
Last activity: 07.03.2024
Categories: MedtechInterestDrugDevelopmentDataBioTechApp
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Followers
331
Mentions
25
Location: United States, California, Encinitas
Employees: 11-50
Total raised: $68.4M
Founded date: 2007

Investors 3

Funding Rounds 2

DateSeriesAmountInvestors
05.11.2021-$50M-
05.04.2017Series B$18.4M-

Mentions in press and media 25

DateTitleDescriptionSource
07.03.2024Viracta Therapeutics Reports Fourth Quarter and Full Year 20...-globenewsw...
31.01.2022Viracta Therapeutics Announces First Patient Dosed in Phase ...SAN DIEGO, Jan. 31, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco...marketscre...
29.11.2021Viracta Therapeutics Announces Orphan Drug Designation Grant...SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco...marketscre...
08.11.2021Viracta Therapeutics Secures $50 Million Credit Facility fro...SAN DIEGO - Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company primarily focuse...marketscre...
05.11.2021Viracta Therapeutics, Inc. Secures $50 Million Credit Facili...ViractaTherapeutics, Inc. announced that the Company has entered into a loan and security agreement ...marketscre...
05.11.2021Viracta Therapeutics Secures $50 Million Credit Facility fro...Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and Oxford Finance...marketscre...
05.11.2021Viracta Therapeutics Secures $50 Million Credit Facility fro...SAN DIEGO, Nov. 5, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncol...marketscre...
16.08.2021Viracta Therapeutics Announces the Appointment of Flavia Bor...prnewswire...
21.07.2021Viracta Therapeutics : Announces FDA Clearance of IND Applic...SAN DIEGO, July 21, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision onco...marketscre...
21.07.2021Viracta Therapeutics Announces FDA Clearance of IND Applicat...prnewswire...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In